Axogen (AXGN) director Paul Thomas receives $235K RSU grant vesting in 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

THOMAS PAUL reported acquisition or exercise transactions in this Form 4 filing.

Axogen, Inc. director Paul Thomas reported receiving a grant of 5,579 restricted stock units as equity compensation for his Board service. Each unit represents one share of common stock and the award is valued at $235,000 as of the grant date. The restricted stock units vest on June 24, 2027, the one-year anniversary of the grant date, and Thomas’s directly held derivative position from this grant totals 5,579 units after the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider THOMAS PAUL

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	5,579	$0.00	--

Holdings After Transaction: Restricted Stock Units — 5,579 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

Key Figures

RSUs granted: 5,579 units Grant valuation: $235,000 Price per RSU: $0.0000 +3 more

6 metrics

RSUs granted 5,579 units Restricted stock unit award for Board service

Grant valuation $235,000 Equity grant value as of grant date

Price per RSU $0.0000 Reported transaction price per unit

Shares underlying RSUs 5,579 shares Each RSU equals one share of common stock

Holdings after grant 5,579 RSUs Total derivative holdings from this award

Vesting date June 24, 2027 One-year anniversary of grant date

Key Terms

Restricted Stock Units, equity grant, contingent right, vests, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

equity grant financial

"Annual equity grant for service as Director on the Axogen, Inc. Board"

contingent right financial

"represents a contingent right to receive one share of Axogen, Inc. common"

vests financial

"and vests on June 24, 2027, the one-year anniversary of the grant date"

derivative financial

"transaction_type": "derivative", "security_title": "Restricted Stock Units""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 04:53 PM Accepted by SEC EDGAR 06/26/2026 - 04:52 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

THOMAS PAUL

(Last)

(First)

(Middle)

C/O AXOGEN, INC. 13631 PROGRESS BLVD

SUITE 400

(Street)

ALACHUA

FLORIDA

32615

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Axogen, Inc. [ AXGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/24/2026		A		5,579		⁽²⁾	⁽²⁾	Common Stock	5,579	$0	5,579	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

2. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.

Remarks:

	/s/ Marc Began, as attorney-in-fact for Paul Thomas	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Axogen (AXGN) director Paul Thomas report in this Form 4?

Paul Thomas reported receiving 5,579 restricted stock units as equity compensation for service on Axogen’s Board of Directors. The award is in the form of derivatives that each convert into one share of common stock upon settlement.

How large is Paul Thomas’s new Axogen (AXGN) RSU award?

The award covers 5,579 restricted stock units, each tied to one share of common stock. According to the disclosure, the equity grant is based on a total valuation of $235,000 as of the grant date for his director service.

When do Paul Thomas’s Axogen (AXGN) restricted stock units vest?

The restricted stock units vest on June 24, 2027, which is the one-year anniversary of the grant date. Vesting means the units become earned and eligible to settle into Axogen common shares at that time, subject to applicable conditions.

What does each Axogen (AXGN) restricted stock unit represent in this filing?

Each restricted stock unit represents a contingent right to receive one share of Axogen common stock. The units are a form of stock-based compensation and do not involve any cash exercise price according to the reported transaction details.

Is the Paul Thomas Axogen (AXGN) Form 4 a market buy or sell?

No, the Form 4 reflects a grant or award acquisition coded as “A,” not an open-market trade. It is compensation in the form of restricted stock units, with a reported transaction price of $0.0000 per unit and no shares sold in this filing.

How many Axogen (AXGN) RSUs does Paul Thomas hold from this grant after the transaction?

After this transaction, Paul Thomas holds 5,579 restricted stock units from this specific grant. The filing lists this total as his derivative holdings following the award, all reported as directly owned, with no remaining option or warrant positions shown.